share_log

23andMe | 8-K: 23andme Announces Fda Clearance of Ind Application for Its Dual Mechanism Antibody, 23me-01473, Targeting Ulbp6

SEC announcement ·  Jan 31 07:51
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more